Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

KalVista Pharmaceuticals (KALV) Non Operating Income: 2014-2025

Historic Non Operating Income for KalVista Pharmaceuticals (KALV) over the last 7 years, with Apr 2025 value amounting to $3.5 million.

  • KalVista Pharmaceuticals' Non Operating Income fell 6.88% to $3.5 million in Q2 2025 from the same period last year, while for Apr 2025 it was $15.2 million, marking a year-over-year increase of 12.00%. This contributed to the annual value of $7.9 million for FY2025, which is 42.45% down from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Non Operating Income of $3.5 million as of Q2 2025, which was down 6.04% from $3.8 million recorded in Q3 2024.
  • In the past 5 years, KalVista Pharmaceuticals' Non Operating Income registered a high of $4.1 million during Q1 2024, and its lowest value of $3.5 million during Q2 2025.
  • Moreover, its 2-year median value for Non Operating Income was $3.8 million (2024), whereas its average is $3.8 million.
  • Data for KalVista Pharmaceuticals' Non Operating Income shows a maximum YoY fell of 6.88% (in 2025) over the last 5 years.
  • KalVista Pharmaceuticals' Non Operating Income (Quarterly) stood at $3.8 million in 2024, then decreased by 6.88% to $3.5 million in 2025.
  • Its Non Operating Income was $3.5 million in Q2 2025, compared to $3.8 million in Q3 2024 and $3.8 million in Q2 2024.